Synthetic data only. Never enter patient information; nothing is sent or stored. For clinicians. Not FDA cleared.For licensed clinicians. Educational demonstration on synthetic data. Never enter real patient identifiers or protected health information: everything runs in your browser and nothing is sent or stored. Clinical decision support only; not FDA cleared; physician review is required.
CPE-005 · Scope and validity
LV-ALC-01: Alcohol intake category
Alcohol intake category. Evaluates alcohol intake entered.
Condition
- alcohol intake entered
What it reports
- MASLD range: under 20 g/day (women) or 30 g/day (men)
- MetALD range: 20–50 g/day (women) or 30–60 g/day (men)
- Alcohol-related liver disease predominant: over 50 g/day (women) or 60 g/day (men)
Diagnostic boundary
- Intake is self-reported; direct biomarkers are not used here.
Evidence
- EV-DELPHI-2023Rinella ME, Lazarus JV, Ratziu V, et al. A multisociety Delphi consensus statement on new fatty liver disease nomenclature. Hepatology. 2023;78(6):1966-1986.Supports: MASLD criteria: steatosis plus at least one cardiometabolic risk factor and no other cause MetALD and alcohol-related liver disease separated by intake
Cases where this rule fires
Open a case to see this rule fire with real inputs, then change the values until it stops.
LIVER-FX-01
Steatosis with metabolic risk and a low FIB-4
A 52-year-old man with fatty liver on ultrasound, BMI 31 and triglycerides 190.
LIVER-FX-03
Indeterminate FIB-4
FIB-4 of 2.0 in a 56-year-old with steatosis.
LIVER-FX-04
High FIB-4
FIB-4 above 5 in a 63-year-old man with low platelets.
LIVER-FX-05
FIB-4 of 1.65 at age 70
Low risk under the age-adjusted cutoff of 2.0.
LIVER-FX-06
Stiffness 14 kPa with a low FIB-4
Discordant tests: the elastography result prevails as a warning.
LIVER-FX-07
ELF 10.1
A high ELF with FIB-4 in the indeterminate range.
LIVER-FX-08
Alcohol in the MetALD range
A woman drinking about 35 g a day with steatosis and metabolic risk.
LIVER-FX-09
Alcohol-related liver disease predominant
About 90 g a day in a man with steatosis.
Try Biod in your practice
The Clinical Intelligence Layer — transforming fragmented clinical information into structured intelligence for clinician review and action.